Topic: Renal Failure

The distinction between "Track One" (terminal) and "Track Two" (non-terminal) euthanasia in Canada is explained. Kelsey Sharon cites a BMJ report on safeguard failures, including a case where a patient was euthanized despite requesting palliative care. She describes the physiological process of the lethal injection, alleging it causes the patient to drown in their own fluids while paralyzed.

Dr. Chris Shoemaker claims that DARPA research from 2015 identified ivermectin as a top product for treating coronavirus pandemics, yet this information was suppressed by the CDC. Dr. Paul Marrick reports that hospitals were incentivized to use Remdesivir, despite World Health Organization data suggesting it increases the risk of kidney failure 20-fold. The federal government reportedly provided a 20% bonus to hospitals for using these specific protocols.

Attorneys Michael Hamilton and Dan Watkins discuss lawsuits filed in Fresno, California, against hospitals using Remdesivir. They claim the drug, which failed Ebola trials due to high mortality rates, is being used in a standardized protocol that leads to kidney failure and death. The attorneys allege that hospitals are financially incentivized to use the drug and isolate patients from their families, effectively performing "euthanasia."

A video segment details the history of Remdesivir, noting it was originally pulled from Ebola trials due to high toxicity and renal failure. The report alleges that Dr. Fauci committed scientific misconduct by changing the study's endpoints to ensure approval. Furthermore, it claims the federal government provides a 20% bonus to hospitals that prescribe the toxic drug to Medicare patients.

A French study of five COVID-19 patients treated with Remdesivir resulted in two deaths and two kidney transplants, leading the country to reject the drug. Dr. Ardis cites World Health Organization data showing a 20-fold increase in renal failure reports for Remdesivir compared to other drugs. He criticizes U.S. hospitals for failing to perform sputum tests to differentiate between viral pneumonia and drug-induced edema.